About AggreDYNE
AggreDYNE is a company based in Houston (United States) founded in 2011.. AggreDYNE has raised $3 million across 1 funding round. AggreDYNE offers products and services including AggreGuide A-100. AggreDYNE operates in a competitive market with competitors including Accumetrics, COC Pharmaceuticals Industry, Zabit Pharmaceutical, ThrombusCheck and DCM Pharmaceutical Industry, among others.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Agoradyne, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3 M (USD)
in 1 rounds
-
Latest Funding Round
$3 M (USD), Series A
Apr 23, 2012
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AggreDYNE
AggreDYNE offers a comprehensive portfolio of products and services, including AggreGuide A-100. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
System for assessing platelet function using light scattering technology.
Funding Insights of AggreDYNE
AggreDYNE has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Series A round of $3 million completed in April 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $3.0M
-
First Round
First Round
(23 Apr 2012)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2012 | Amount | Series A - AggreDYNE | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by AggreDYNE
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AggreDYNE
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aggredyne Comparisons
Competitors of AggreDYNE
AggreDYNE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accumetrics, COC Pharmaceuticals Industry, Zabit Pharmaceutical, ThrombusCheck and DCM Pharmaceutical Industry, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Platelet function assays and coagulation systems are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Develops diagnostic devices for platelet function analysis.
|
|
| domain | founded_year | HQ Location |
Develops innovative devices for platelet functioning tests.
|
|
| domain | founded_year | HQ Location |
Offers a device that mimics plaqued arteries for personalized anti-platelet therapy.
|
|
| domain | founded_year | HQ Location |
Creates innovative diagnostic devices for measuring platelet dysfunction in healthcare.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about AggreDYNE
When was AggreDYNE founded?
AggreDYNE was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is AggreDYNE located?
AggreDYNE is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Is AggreDYNE a funded company?
AggreDYNE is a funded company, having raised a total of $3M across 1 funding round to date. The company's 1st funding round was a Series A of $3M, raised on Apr 23, 2012.
What does AggreDYNE do?
AggreDYNE was founded in 2011 and is headquartered in Houston, United States. Operations center on platelet function monitoring in the medical diagnostics sector. The patented Aggreguide A-100 device is employed to assess blood platelet stickiness and evaluate responses to anti-platelet therapies, such as aspirin and ADP inhibitors. Distribution occurs through 16 partners spanning 38 countries.
Who are the top competitors of AggreDYNE?
AggreDYNE's top competitors include Accumetrics, COC Pharmaceuticals Industry and Zabit Pharmaceutical.
What products or services does AggreDYNE offer?
AggreDYNE offers AggreGuide A-100.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.